Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: Cell kinetic features of neuroendocrine cells in the human prostate

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1759-1765

  Xue, Yong ^a   Verhofstad, Albert ^a   Lange, Wil ^a   Smedts, Frank ^b   Debruyne, Frans ^a   De La Rosette, Jean ^a   Schalken, Jack ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Found Collaborating Hospitals E G ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN;

ARTICLE; CELL KINETICS; CYTOCHEMISTRY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROSECRETORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE DISEASE; STEM CELL; TISSUE PREPARATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; KERATINS; MALE; NEUROSECRETORY SYSTEMS; PARAFFIN EMBEDDING; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEROTONIN;

EID: 0030662970     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Di Sant'Agnese PA: Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992, 23:287-296
2. Cohen RJ, Glezerson G, Taylor LF, Grundle HA, Naude JH: The neuroendocrine cell population of the human prostate gland. J Urol 1993, 150:365-368
3. Di Sant'Agnese P: Neuroendocrine differentiation in prostatic carcinoma: recent findings and new concepts. Cancer 1995, 75: 1850-1859
4. Cockett AT, di Sant'Agnese PA, Gopinath P, Schoen SR, Abrahamsson PA: Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia. Urology 1993, 42:512-519
5. Weinstein MH, Partin AW, Veltri RW, Epstein JI: Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum Pathol 1996, 27:683-687
6. Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P, Mihatsch MJ: Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol 1996, 178:437-441
7. Aprikian AG, Cordon Cardo C, Fair WR, Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993, 71:3952-3965
8. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994, 25:42-46
9. Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch A Pathol Anat Histopathol 1993, 423:291-294
10. Nakada SY, di Sant'Agnese PA, Moynes RA, Hiipakka RA, Liao S, Cockett AT, Abrahamsson PA: The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Cancer Res 1993, 53:1967-1970
11. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 1996, 28:98-106
12. Lu QL, Abel P, Foster CS, Lalani EN: bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996, 27:102-110
13. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462
14. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992, 52:6940-6944
15. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88:6961-6965
16. Segal NH, Cohen RJ, Haffejee Z, Savage N: BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Arch Pathol Lab Med 1994, 118:616-618
17. Moll R, Franke WW, Schiller DL, Geiger B, Krepier R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24
18. Ramaekers FCS, Smedts F, Vooijs PG: Keratins as differentiation markers in tumor biology and surgical pathology. Current Perspectives on Molecular and Cellular Oncology, vol 1, part A. Edited by Spandidos D. London, JAI Press, 1992. pp 285-318
19. Nagle RB: A review of intermediate filament biology and their use in pathologic diagnosis. Mol Biol Rep 1994, 19:3-21
20. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA: Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988, 13:25-38
21. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA: Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992, 52:6182-6187
22. Xue Y, Umbas R, Smedts F, Aalders TW, Debruyne FMJ, de la Rosette JJMCH, Schalken JA: Changes in keratin expression during the development of benign prostatic hyperplasia (BPH). Eur Urol 1997, 32:332-338
23. Xue Y, Smedts F, Debruyne FMJ, de la Rosette JJMCH, Schalken JA: Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate (in press)
24. Isaacs JT, Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989, 2:33-50
25. Bonkhoff H, Stein U, Remberger K: Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 1995, 26:167-170
26. Verhofstad AAJ, Steinbusch HWM, Joosten HWJ, Penke B, Varga J, Goldstein M: Immunocytochemical localization of noradrenaline. adrenaline and serotonin. Immunocytochemistry: Practical Applications in Pathology and Biology. Edited by Polak JM, van Noorden S. Bristol, UK, Wright, 1983, pp 143-168
27. Van de Voorde W, Baldewijns M, Lauweryns J: Florid basal cell hyperplasia of the prostate. Histopathology 1994, 24:341-348
28. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S: Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol 1992, 421:157-161
29. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R: Detection of the apoptosissuppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 1993, 143:390-400
30. Ubink R, Lange W, Verhofstad A: Simultaneous immunoenzymatic staining of catecholamines, catecholamine-biosynthesizing enzymes, and bromodeoxyuridine in adrenal medullary cells of the rat. J Histochem Cytochem 1995, 43:39-46
31. Larsson LI: Associated methods. I. Immunocytochemical demonstration of multiple antigens. Immunocytochemistry: Theory and Practice. Boca Raton, FL, CRC Press, 1988, pp 171-184
32. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995, 146:1309-1319
33. Coppola D, Clarke M, Landreneau R, Weyant R, Cooper D, Yousem S: Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Modern Pathol 1996, 9:484-490
34. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995, 267:1506-1510
35. Boise LH, Gonzalez Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608
36. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC: Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996, 148:1567-1576
37. Jen PY, Dixon JS: Development of peptide-containing nerves in the human fetal prostate gland. J Anat 1995, 187:169-179
38. Hsieh TC, Xu W, Chiao JW: Growth regulation and cellular changes during differentiation of human prostatic cancer LNCaP cells as induced by T lymphocyte-conditioned medium. Exp Cell Res 1995, 218:137-143
39. Sjoberg HE, Arver S, Bucht E: High concentration of immunoreactive calcitonin of prostatic origin in human semen. Acta Physiol Scand 1980, 110:101-102
40. Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Link M, Lane B, Leigh I, Schijf C, Vooijs P: Keratin expression in cervical cancer. Am J Pathol 1992, 141:497-511
41. Verhofstad AA: Kinetics of adrenal medullary cells. J Anat 1993, 183:315-326
42. De Bruine AP, Dinjens WN, van der Linden EP, Pijls MM, Moerkerk PT, Bosman FT: Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells. Am J Pathol 1993, 142:773-782
43. Noordzij MA, van Weerden WM, de Ridder CM, van der Kwast TH, Schroder FH, van Steenbrugge GJ: Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol 1996, 149:859-871
44. Jongsma J, Oomen MH, Noordzij MA, van Weerden WM, van der Kwast TH, Schroder FH, van Steenbrugge GJ: Neuroendocrine differentiation in the PC-295 human prostate cancer xenograft model Urol Res 1997, 25:74